NEW YORK (GenomeWeb) – Roche announced this week that it has expanded its Global Access Program for HIV to provide its dual-target cobas HIV test running on the cobas 4800 System and the cobas 6800/8800 Systems at an affordable price for qualifying organizations in 82 eligible countries with the highest disease burden.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.